Dr. Linda Kelley is a Senior Member and Director of the Cell Therapy facility at Moffitt Cancer Center.  Previously she was the head of the Cell Therapy facility at Dana Farber Cancer Institute at Harvard.  As director of the Cell Therapy Facility at Moffitt Cancer Center, Dr. Kelley is responsible for manufacture and compliance of approved cell therapies for stem cell transplantation of malignant and benign disease, as well as experimental therapies for immune modulation of cancer treatment.  In this capacity, she oversees 22 investigational new drug applications for on-going clinical trials.  Dr. Kelley received her PhD in Pathology and Immunology at Vanderbilt University, where she also completed a fellowship in Hematology.